Replies to post #7807 on RespireRx Pharmaceuticals Inc (fka RSPI)

[neuroinv]

<<What have they been doing, if not negotiating a BP deal?>>

Jim--I believe I covered that in my post. If all of us are indeed right, then a CC announcing the IND and resolution of Neurology's inquiry will have the effect of providing Cortex with a tail wind--seemingly similar to what you suggested, but with a much different impact.

NeuroInvestment

[ggg7ggg]

Jim,
Based on your posts, I fear you will be disappointed in the CC. Nonetheless, i look forward to it, and think it will be a positive for the pps.

[haysaw]

Underwhelming indeed, at least for me. We have known since early in the year that Cortex' goal was to submit an IND for CX-717. If the conference call simply lets us know they just submitted it, then the only thing that that gives us is another timeline for a binary event (30 days max). Wouldn't they just release a PR for that? Save the bells and whistles of a CC for something bigger.